Cartesian Therapeutics, Inc. (RNAC)
NASDAQ·Healthcare·Biotechnology
$6.89
-2.82%
Mkt Cap $234.55M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 9, 2026 | $150.33K | $947.00K | +529.93% | -$0.82 | -$1.38 | -68.29% | — | — |
| Q4 2025 Nov 6, 2025 | $100.22K | $452.00K | +351.01% | -$0.81 | -$1.38 | -70.37% | — | — |
| Q3 2025 Aug 7, 2025 | $177.56K | $298.00K | +67.83% | -$0.76 | $0.50 | +165.79% | — | — |
| Q2 2025 May 8, 2025 | $687.50K | $1.10M | +60.00% | -$0.61 | -$0.68 | -11.48% | — | — |
| Q1 2025 Mar 20, 2025 | $1.00M | $759.00K | -24.10% | -$0.78 | -$0.59 | +24.36% | — | — |
| Q4 2024 Nov 7, 2024 | $114.29K | $387.00K | +238.61% | -$0.78 | -$0.69 | +11.54% | — | — |
| Q3 2024 Aug 8, 2024 | $2.54M | $33.45M | +1216.73% | -$1.07 | $0.54 | +150.47% | — | — |
| Q2 2024 May 8, 2024 | $1.67M | $5.84M | +250.40% | -$0.81 | -$1.97 | -143.21% | — | — |
| Q1 2024 Mar 7, 2024 | $5.87M | $8.27M | +40.82% | -$0.30 | -$2.40 | -700.00% | — | — |
| Q4 2023 Nov 13, 2023 | $7.23M | $6.55M | -9.39% | -$2.10 | -$2.40 | -14.29% | — | — |
| Q3 2023 Aug 17, 2023 | $5.60M | $5.25M | -6.27% | -$0.09 | -$0.07 | +22.22% | — | — |
| Q1 2023 Mar 31, 2023 | $12.14M | $5.94M | -51.08% | -$2.60 | -$0.17 | +93.48% | — | — |
| Q4 2022 Dec 30, 2022 | $11.68M | $16.80M | +43.74% | -$2.17 | $0.05 | +102.13% | — | — |
| Q3 2022 Sep 29, 2022 | $25.21M | $20.71M | -17.86% | -$0.17 | -$0.06 | +63.85% | — | — |
| Q2 2022 Jun 29, 2022 | $13.78M | $39.27M | +184.97% | -$2.27 | $0.07 | +103.06% | — | — |
| Q1 2022 Mar 30, 2022 | — | $34.00M | — | — | $0.27 | — | — | — |
| Q4 2021 Dec 30, 2021 | $12.14M | $29.94M | +146.62% | -$3.35 | $0.12 | +103.53% | — | — |
| Q3 2021 Sep 29, 2021 | — | $24.43M | — | — | -$0.19 | — | — | — |
| Q2 2021 Jun 29, 2021 | — | $19.66M | — | — | $0.05 | — | — | — |
| Q1 2021 Mar 30, 2021 | — | $11.05M | — | — | -$0.27 | — | — | — |